Google DeepMind CEO Demis Hassabis Targets 2030 for AGI, Predicts AI-Driven Medical Breakthroughs

Demis Hassabis, CEO of Google DeepMind, said on May 29, 2026 that artificial general intelligence is on track for 2030, plus or minus one year, matching the 20-year timeline set at the company's founding. Hassabis said his confidence interval has narrowed sharply, as technical progress aligns with precise roadmaps. Google has restructured its entire technology stack for an "agent-first" era, moving beyond AI-first design, Hassabis said. New Gemini Flash 3.5 and Omni models will integrate into the Anti-gravity 2.0 system as productivity tools. However, he noted current AI still shows "jagged intelligences," lacking robust physical-world understanding, long-term planning, and memory. On the scientific front, Hassabis hailed AI-driven drug discovery as a potential watershed. Isomorphic Labs, a DeepMind subsidiary, is working to compress a decade-long development cycle to weeks or months, with test compounds already in pre-clinical trials for oncology and immunology. He predicted AI could cure major diseases within a lifetime. Hassabis added that future human value will depend on creativity, design sense, and emotional connection, warning that cybersecurity risks demand urgent international safety standards.